SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001679082-20-000041
Filing Date
2020-08-11
Accepted
2020-08-11 08:36:49
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q myov-20200630.htm   iXBRL 10-Q 1549409
2 EX-10.1 a06302020myovant10qex1.htm EX-10.1 75595
3 EX-31.1 myovantex31106302020.htm EX-31.1 12757
4 EX-31.2 myovantex31206302020.htm EX-31.2 12991
5 EX-32.1 myovantex32106302020.htm EX-32.1 7940
6 EX-32.2 myovantex32206302020.htm EX-32.2 7741
  Complete submission text file 0001679082-20-000041.txt   5937416

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myov-20200630.xsd EX-101.SCH 40318
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myov-20200630_cal.xml EX-101.CAL 69329
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myov-20200630_def.xml EX-101.DEF 209785
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myov-20200630_lab.xml EX-101.LAB 465786
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myov-20200630_pre.xml EX-101.PRE 321229
12 EXTRACTED XBRL INSTANCE DOCUMENT myov-20200630_htm.xml XML 818623
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37929 | Film No.: 201091168
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences